Distributor Novo Nordisk has decided to limit low doses of obesity medication Wegovy in the U.S. as demand outpaces supply. Novo Nordisk, a global healthcare and pharmaceutical company based in Denmark, is limiting the supply of Wegovy to conserve supply for patients already using the drug, the…
#wegovyinus #novonordisk #denmark #wegovy #glp1 #cbsnews
Continue reading...